Literature DB >> 8487279

Prevalence of cystic fibrosis mutations in the Grampian region of Scotland.

Z H Miedzybrodzka1, J C Dean, G Russell, J A Friend, K F Kelly, N E Haites.   

Abstract

We have identified all known sufferers of cystic fibrosis (CF) alive in the Grampian region, north east Scotland, on 1 January 1989. DNA samples were obtained for a prevalence study of the common mutations with near to complete ascertainment. A relatively high prevalence of the delta F508 mutation was found (82%), with one of four mutations being present on 92% of CF chromosomes. The high prevalence of these four easily detectable mutations in Grampian has local implications for genetic counselling, the efficacy of population carrier screening, and the usefulness of mutation analysis in cases where the diagnosis of CF is in doubt.

Entities:  

Mesh:

Year:  1993        PMID: 8487279      PMCID: PMC1016342          DOI: 10.1136/jmg.30.4.316

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  6 in total

1.  Mutation analysis of 184 cystic fibrosis families in Wales.

Authors:  J Cheadle; J Myring; L al-Jader; L Meredith
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

2.  Prenatal diagnosis for the cystic fibrosis mutation 1717-1, G-->A using arms.

Authors:  Z H Miedzybrodzka; K F Kelly; M Davidson; S Little; A E Shrimpton; J C Dean; N E Haites
Journal:  Prenat Diagn       Date:  1992-10       Impact factor: 3.050

3.  The incidence of different cystic fibrosis mutations in the Scottish population: effects on prenatal diagnosis and genetic counselling.

Authors:  A E Shrimpton; I McIntosh; D J Brock
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

4.  [Gene mutations of cystic fibrosis in Brittany population].

Authors:  C Ferec; H Guillermit; A Chaventre
Journal:  Pathol Biol (Paris)       Date:  1991-06

5.  Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene.

Authors:  R M Ferrie; M J Schwarz; N H Robertson; S Vaudin; M Super; G Malone; S Little
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

6.  Cystic fibrosis in the Basque country: high frequency of mutation delta F508 in patients of Basque origin.

Authors:  T Casals; C Vázquez; C Lázaro; E Girbau; F J Giménez; X Estivill
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

  6 in total
  4 in total

1.  Analysis of the complete coding region of the CFTR gene in a cohort of CF patients from north-eastern Italy: identification of 90% of the mutations.

Authors:  A Bonizzato; L Bisceglia; C Marigo; E Nicolis; C Bombieri; C Castellani; G Borgo; L Zelante; G Mastella; G Cabrini
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

2.  Evaluation of laboratory methods for cystic fibrosis carrier screening: reliability, sensitivity, specificity, and costs.

Authors:  Z H Miedzybrodzka; Z Yin; K F Kelly; N E Haites
Journal:  J Med Genet       Date:  1994-07       Impact factor: 6.318

3.  Cost effectiveness of antenatal screening for cystic fibrosis.

Authors:  H S Cuckle; G A Richardson; T A Sheldon; P Quirke
Journal:  BMJ       Date:  1995-12-02

4.  Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening.

Authors:  Z H Miedzybrodzka; M H Hall; J Mollison; A Templeton; I T Russell; J C Dean; K F Kelly; T M Marteau; N E Haites
Journal:  BMJ       Date:  1995-02-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.